Alternatives
Alternatives to Layla
Layla scores 57/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
Layla at a glance
- Semaglutide
- $1,399/moBrand Ozempic, promotional rate
- Tirzepatide
- $1,399/moBrand Mounjaro, promotional rate
- Coverage
- Coverage not published
- Brand-name GLP-1s
- Yes
- Oral option
- No
- Pricing verified
- October 2026
7 of the 8 programs below list semaglutide for less than Layla's $1,399 a month. 7 of the 8 list tirzepatide for less than its $1,399 a month.
Layla is a US telehealth weight-loss brand that now sells only FDA-approved branded GLP-1s Ozempic, Wegovy, Zepbound and Mounjaro starting around $1,399/mo, all-inclusive of health check-ins, telehealth visits and unlimited doctor messaging.
Best for: Shoppers who want brand-name Ozempic, Wegovy, Zepbound or Mounjaro with check-ins included and don't need a lower-cost compounded option.
What Layla does well
- All-inclusive pricing bundles health check-ins, telehealth visits, prescription and unlimited doctor messaging into one price
- Names its Medical Director (Dr. Ruth Cohen) on its site
- LegitScript-certified badge displayed; fast 2-3 day shipping claimed
Why readers look for an alternative
- Brand-only and expensive: the real floor is $1,399/mo (Ozempic/Mounjaro), not the $1,299 the homepage FAQ separately claims — the two figures don't reconcile
- The lowest Zepbound figure shown ($1,599) is a one-time new-customer discount off a $1,699 standing price, not an ongoing rate
- No compounded or lower-cost option on the current site, and states served are not published
- $100 nonrefundable visit/clinical fee applies if you cancel after a prescription is already sent to the pharmacy
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
Compared with Layla: $1,300/mo less for semaglutide · $1,250/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 02C58/ 100Index
Mixx Health & Wellness
Mixx Health & Wellness offers a compounded GLP-1/GIP program through Elevis Medical Group, with a named medical director and Promise Pharmacy listed as a dispensing partner.
- Sema
- Not disclosed
- Tirz
- Not disclosed
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Layla: compounded only, no brand-name GLP-1s
- 03C58/ 100Index
Bon Health
Bon Health is a physician-led GLP-1 weight-loss telehealth service selling compounded semaglutide and tirzepatide on commitment tiers.
- Sema
- $220/moMonth-to-month, compounded; $95/mo with $1,140 annual prepay
- Tirz
- $285/moMonth-to-month, compounded; $135/mo with $1,620 annual prepay
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Layla: $1,179/mo less for semaglutide · $1,114/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 04C58/ 100Index
Nova MD
Nova MD (Try Nova) sells compounded semaglutide and tirzepatide on one-month and three-month plans, with the online visit, the medication and overnight shipping in one monthly price and no membership fee.
- Sema
- $175/moMonth to month (compounded; less on a 3-month plan)
- Tirz
- $199/moMonth to month (compounded; less on a 3-month plan)
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Layla: $1,224/mo less for semaglutide · $1,200/mo less for tirzepatide · compounded only, no brand-name GLP-1s
Regulatory note: the FDA issued a warning letter to Try Nova in September 2025. We still list and link to Nova MD; you should know the letter is on the public record before you decide.
- 05C58/ 100Index
TeleCareSpot
TeleCareSpot is a telehealth weight-loss service with monthly programs for semaglutide from $299 and tirzepatide from $399, plus oral tirzepatide and phentermine, and it displays LegitScript verification.
- Sema
- $299/moCompounded; from price, monthly program
- Tirz
- $399/moCompounded; from price, all dose levels included
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Layla: $1,100/mo less for semaglutide · $1,000/mo less for tirzepatide · compounded only, no brand-name GLP-1s · offers an oral option
- 06C58/ 100Index
MedLeanRx
MedLeanRx is a Spring, Texas-based telehealth weight-loss clinic serving Texas exclusively.
- Sema
- $149/moCompounded oral
- Tirz
- $269/moCompounded
- Coverage
- 1 state
- Brand
- Yes
Compared with Layla: $1,250/mo less for semaglutide · $1,130/mo less for tirzepatide · offers an oral option
- 07C58/ 100Index
LaSara Medical Group
LaSara Medical Group offers compounded injections through Southern California clinics and telehealth, with monthly subscriptions at $289 for semaglutide and $379 for tirzepatide.
- Sema
- $289/moCompounded monthly subscription; $299 one-month purchase
- Tirz
- $379/moCompounded monthly subscription; $399 one-month purchase
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Layla: $1,110/mo less for semaglutide · $1,020/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 08C57/ 100Index
LumiMeds
LumiMeds is a telehealth platform selling compounded semaglutide 'as low as $89/mo' and compounded tirzepatide 'as low as $125/mo' on fixed-term monthly, 3-, 6- and 12-month plans, with Klarna financing.
- Sema
- $89/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $39
- Tirz
- $125/moAs low as, fixed-term plan, plan length not stated, compounded; first month as low as $75
- Coverage
- Multi-state
- Brand
- Compounded
Compared with Layla: $1,310/mo less for semaglutide · $1,274/mo less for tirzepatide · compounded only, no brand-name GLP-1s
Regulatory note: the FDA issued a warning letter to Lumimeds in September 2025. We still list and link to LumiMeds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.